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INTERKEUKIN \ ß , TUMOUR NECROSIS 
FACTOR-a AND INTERLEUKIN 1 RECEPTOR 
ANTAGONIST IN NEWLY DIAGNOSED  
INSULIN-DEPENDENT DIABETES MELLITUS: 
COMPARISON TO LONG-STANDING DIABETES
AND HEALTHY INDIVIDUALS
Mihai G. N etea ,13 Nicolae H ancu .1 Willem L. Blok.' 
Paula G rigorescu-Sido,2 Lenuta P opa ,2 Victor Popa,2
Jos W. M. van der M eer'
Interleukin 1 beta (IL-1) and tumour necrosis factor alpha (T N F ) are important for the beta 
cell lysis in insulin-dependent diabetes mellitus ( I D D M ),  while IL-1 receptor antagonist (IL - lra )  
is considered protective by blocking the effects o f  IL-1. Serum concentrations and ex-vivo  
production o f  IL-1, T N F  and IL -lra  were examined in 10 newly diagnosed ID D M  ( N D -I D D M )  
patients, and compared with 11 long-standing ID D M  (L S -I D D M ) patients and 14 healthy 
volunteers. Ex-vivo LPS-stimulated production o f  IL-1 in N D - I D D M  patients was significantly 
increased compared with L S -ID D M  patients and healthy controls, while T N F  and IL-lra  
synthesis did not differ significantly. IL -lra /IL -1  ratio was significantly decreased in 
N D - I D D M , and returned to normal values in the L S -ID D M  group. Circulating concentrations  
of  IL-lra  in L S -ID D M  patients were increased. These data suggest a proinflammatory 
imbalance in N D -I D D M  patients and this may play an important role in beta cell loss.
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Insu lin -dependen t d iabetes  mellitus ( I D D M )  is an 
a u to im m u n e  disease in which beta cell lysis is the 
centra l  ev e n t .1 In this process, the p ro - in f lam m ato ry  
cy tok ines  in terleukin  1 beta ( IL -1 ) and  tu m o u r  necrosis 
fac to r  a lpha  (T N F )  are  th o u g h t  to play an im p o r ta n t  
role. In vitro  studies have show n tha t  IL-1 interferes 
with insulin secretion from pancrea t ic  beta  cells2 
a n d  has a lytic effect on  islet cells.' In traper i tonea l  
ad m in is t ra t io n  o f  IL-1 accelerates the onset o f  ID D M  
in the BB-rat m ode l ,4 and  induces hyperglycemia 
an d  hypoinsu linem ia  in no rm al W is ta r  K yo to  rats." 
A l th o u g h  T N F  bv itself is no t cy to toxic  to the beta cell, 
it s trong ly  p o ten t ia te s  the ac tion  o f  IL -1 /’ In terleukin  
1 recep to r  an tag o n is t  ( IL - l ra ) ,  the na tu ra l ly  occurr ing
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K E Y  W O R D S ;  insu lin-dependent  d iabetes  mellitus in te r leu k in -1 
tu m o u r  necrosis fac tor  in te r leuk in -1 recep tor  an tagon is t
an tag o n is t  o f  IL-1, was show n to p ro tec t  beta-cells 
agains t  the dele terious effects o f  IL-1, '  an d  to delay the 
onset o f  d iabe tes  in BB-rats .s
T he  aim o f  the present s tudy  was to assess the 
p ro-  and  an t i - in f lam m ato ry  cy tok ine  p ro d u c t io n  in 
ID D M  patients . We investigated bo th  c ircu la t ing  and  
ex-vivo p ro d u ced  IL-1 p. TNFot and  IL-ra in newly- 
d iagnosed  ID D M  ( N D - I D D M )  an d  long-s tand ing  
ID D M  (L S - ID D M )  patien ts ,  and  we c o m p a re d  them  
with a g ro u p  o f  healthy  volunteers .
RESULTS
Circulating concentrations o f  IL-1, TNF and 
IL-lra
IL-1 co n cen tra t io n s  were de tec tab le  in se rum  o f  
only 2 o f  10 healthy  vo lun teers  (4.2 an d  5.6 pg/ml), 
4 o f  10 N D - I D D M  patien ts  (range 5-13.5  pg ml) and  
1 o f  11 L S -ID D M  pa tien ts  (5.2 pg/ml). C ircu la t ing  
co n cen tra t io n s  o f  T N F  were below detec tion  limit. 
C ircu la t ing  IL - l r a  co n cen tra t io n s  did no t differ 
between con tro l  individuals  (234 +  216 pg/m l) and  
N D - I D D M  pa tien ts  (184 +  158 pg/ml), but were 
significantly h igher in L S - ID D M  patien ts  (461 ±  
167 pg ml, P  <  0.05) (Fig. 1A).
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Figure 1. Circulating concentrations o f  interleukin I receptor 
antagonist (IL -lra)  ( Q )  in healthy controls, newly diagnosed I D D M  
patients and long-standing I D D M  patients (A) and ex-vivo production 
o f  interleukin-1 beta ( IL- 1) ( ■ )  and tumour necrosis factor alpha 
(T N F )  ($%) after stimulation with I-PS (10 jig/ml) (B).
Results  expressed as m ean  ±  s ta n d a rd  deviation.  *I} <  0.05.
Ex vivo L PS-s t im ula ted  p ro d u c t io n  o f  IL-1 in 
hea lthy  vo lun teers  was 2.1 ±  l .O ng/m l.  In N D - I D D M  
patien ts  the release o f  IL-1 was significantly increased 
(3.2 +  1.2 ng ml, P  <  0.05), w hereas IL-1 p ro d u c t io n  
in L S - ID D M  patien ts  did not differ significantly from 
the con tro l  g ro u p  (1.4 +  1.0 ng ml, P  >  0.05) (Fig. IB). 
S t im u la ted  p ro d u c t io n  o f  T N F  was 3.1 ±  1 .8ng /m l 
in the con tro l  g roup ; in N D - I D D M  patien ts ,  T N F  
synthesis  tended  to be higher, but statistical significance 
was no t  achieved due to a wide range  in the 
observations:  4.9 +  2.7 ng ml. P > 0.05. In L S -ID D M  
patients ,  T N F  synthesis did no t differ from  controls:  
3.0 ± 2 . 1  ng ml, P > 0.05 (Fig. IB). S tim ula ted  p ro ­
duc tion  o f  IL - l r a  did not differ between the three 
g ro u p s  studied: 36.7 ±  9.3 ng/ml in healthy  volunteers ,
33.2 ±  9.9 ng ml in N D - I D D M  patien ts  and 
33.7 ±  14.3 ng/ml in L S -ID D M  patients . Because an 
im balance  between the p ro - in f lam m ato ry  IL-1 and  
the an t i - in f lam m ato ry  I L - l r a  may be involved in the 
pa thogenesis  o f  ID D M . the a u th o rs  ca lcu la ted  the 
IL - lra /IL -1  ratios: in healthy  con tro ls  the ra t io  was
21.3 ± 8 . 9 ,  in N D - I D D M  it was s trongly  reduced:
I 1.5 ± 4 . 2  ( /3 < 0 .0 2 ) ,  while in L S -ID D M  patien ts  
the ra tio  did not differ significantly from controls:
32.1 ±  21.6 ( P >  0.05).
Similar results have been ob ta ined  when the 
rad io - im m u n o assay  was used to de te rm ine  the cy tok ine  
co n cen tra t io n s  (da ta  not show n), a rgu ing  for the 
accuracy  o f  the com m ercia lly  ELISA  kits used for 
the de te rm ina tions .
ID D M  is charac te r ized  by m o n o n u c le a r  cell 
infiltration o f  the islets o f  L angerhans ,  associa ted  with 
a selective [3-cell lysis. Recent studies suggest tha t  the 
p ro - in f lam m ato ry  cy tok ine  IL-1 plays a m a jo r  role in 
the inhib ition  o f  insulin secre t ion2 an d  in the lysis 
o f  (3-cells.3 T N F ,  a n o th e r  m a jo r  p ro - in f lam m ato ry  
cytokine , s trong ly  increases the effects o f  IL -1 /’ In the 
present s tudy  we show  tha t  non -ke to t ic  N D - I D D M  
patien ts  have an  increased p ro d u c t io n  capacity  o f  
IL-1 and  a tendency to w ard s  h igher synthesis o f  T N F  
when c o m p a re d  with hea lthy  contro ls .  A pparen t ly ,  the 
cy tok ine  p ro d u c t io n  capac ity  re tu rns  to n o rm al  values 
with longer d u ra t io n  o f  illness.
C o n tra s t in g  d a ta  a re  availab le  in the l i tera ture  
regard ing  the p ro - in f lam m ato ry  cy tok ine  p ro d u c t io n  
capacity  o f  ID D M  patients .  Som e studies do n e  in 
m onocy tes  o f  N D - I D D M  patien ts  did not find any  
difference in IL-1 and  T N F  p ro d u c t io n  w hen co m p ared  
with the con tro ls .1' 10 H ow ever, the longer d u ra t io n  
o f  d iabetes  (68.6 days) in the N D - I D D M  patien ts  
investigated by M olvig  an d  colleagues,9 and  the use o f  
silica as a s tim ulus for cy tok ine  p ro d u c t io n  by Luger 
et a/.'" m akes  difficult the co m p ar iso n  o f  these studies 
with the present da ta .  In con tras t ,  o th e r  investigators  
have found an increased p ro d u c t io n  o f  cy tokines  after  
in vitro s t im ula t ion  o f  b lood m o n o n u c lea r  cells o f  
N D - I D D M  p a t ien ts"  1215 as we also observed in o u r  
system. H ow ever ,  when c o m p a r in g  the present results 
with the d a ta  from  the literature, it is also im por tan t  
to m en tion  tha t  the cy tok ine  p ro d u c t io n  capacity  was 
assessed afte r  whole b lood s t im ula t ion ,  in the presence 
o f  all the cells and  p lasm a factors  norm ally  present in 
c ircu la tion , which represents  a system closer to the 
physiological cond it ions  than  the artificially isolated 
m onocy tes  used in the above-m en tioned  studies. In this 
respect, the a u th o rs  are  aw are  tha t  pancrea tic  cy tok ine  
d e te rm in a t io n s  w ould  have been m ore  meaningful,  
but u n fo r tu n a te ly  there are  no available m e th o d s  to 
ob ta in  pancrea tic  m ateria l  from patien ts  at the present 
m om en t.
A lthough  m etabolic  d is tu rbances  c an n o t  be ruled 
out as a fac to r  in the observed differences in cy tok ine  
p a t te rn s  between the N D - I D D M  and the L S -ID D M  
patients ,  they are  less p robab le  to play a m ajor  
role since the L S -ID D M  patien ts  studied had similar 
fasting blood glucose an d  glycated haem oglob in  with 
the N D - I D D M  group ,  a n d  all ID D M  patien ts  were 
non -ke to t ic  at the time o f  sampling.
In view o f  the reports  tha t  have show n tha t  ID D M  
patien ts  have an  increased ex-vivo p roduc t ion  o f  IL-1 
beta  and  T N F  a lpha  when co m p ared  with genotype- 
m atched  healthy c o n t ro ls ,14 a n d  the finding tha t  
T N F  p roduc t ion  is higher in individuals  with D R 3  and  
D R 4  haplo types,  which are m ore  prevalent in ID D M ,
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TABLE 1. Clinical characteristics of IDDM patients and healthy volunteers*
N D - I D D M L S -ID D M C o n tro l s
N u m b e r 10 11 14
Sex (M /F ) 6/4 6/5 8/6
Age (years) 21 (13-23) 27 (12-35) 22 (19-27)
I D D M  d u ra t io n 3.4 days 4.7 years --------------
Insulin ( lU /d a y ) 27.4 ±  12.9 49.9 ±  17.4 --------------
F as t in g  b lood  glucosc (mg dl) 260 ±  70 242 ±  89 94 ±  16
HBAi (% ) 9.4 ±  1.6 8.6 +  1.1 7.1 ±  0.3
* D a ta  are  given as m ean  ±  SI) ,  with  the excep t ion  o f  age which is given as m ed ian  (interval).
it is possible th a t  the “ n o rm a l"  p ro d u c t io n  capac ity  
with longer d u ra t io n  o f  illness represents  a decrease 
o f  genetically increased p ro d u c t io n  capacity . This 
hypothesis  is sus ta ined  by o th e r  studies show ing  a 
decreased  cy tok ine  p ro d u c t io n  capac ity  in pa tien ts  
with L S - I D D M . |S 16 A lternatively , the increased 
capac ity  found can  be due  to the disease process itself 
ra th e r  than  to genetics.
T o  the best o f  the a u th o rs '  know ledge, this s tudy  
is the first to assess the ex vivo IL - I ra  p ro d u c t io n  
capac ity  of' ID D M  patients .  T he  s t im ula ted  p ro d u c t io n  
o f  I L - l r a  did not differ between healthy  individuals  
and  N D -  o r  L S - ID D M  patients .  T he  decrease  of' 
IL - lra /IL -1  ra tio  in N D - I D D M  patien ts  susta ins  
the hypothesis  o f  M a n d ru p -P o u lse n  cl ul. tha t  the 
im balance  between IL-1 and  I L - l r a  is centra l  in the 
au toaggress ive  reaction  against  beta  cell .1 A similar 
im balance  o f  I L - l r a / I L - l  ra tio  was recently found  in 
pa tien ts  with ch ron ic  in f lam m ato ry  bowel d iseases ,ls 
in rh eu m ato id  sy n o v iu m 1'' an d  in the synovial fluid 
o f  Lym e ar th r i t is  p a t ien ts .20
C ircu la ting  co n cen tra t io n s  o f 'T N F  were below the 
detection  limit, as was the case for c ircu la t ing  IL-1 in 
the m ajori ty  o f  samples. T he  differences in serum  
co n cen tra t io n s  o f  I L - l r a  are  difficult to explain. W hile 
in newly d iagnosed  ID D M  pa tien ts  IL - l r a  co n cen ­
tra t ions  were similar to healthy  individuals, we found 
significantly increased co n cen tra t io n s  in long -s tand ing  
ID D M . This  is su p p o r ted  by the finding o f  higher 
IL - l r a  c ircu la ting  co n cen tra t io n s  in ID D M  patien ts  
with the A I /A 2  geno type  for IL - l r a  gene when 
co m p a re d  with co n tro l  subjects with the same 
g en o ty p e .21 T hus ,  it seems that differences in c ircu la ting  
IL - l r a  co n cen tra t io n s  do  a p p e a r  in the course  o f  
I D D M , and  a co rre la t ion  o f  these m odifica tions with 
cer ta in  geno types  can  no t  be excluded.
In conclus ion , we have found  an increased 
IL-1 p ro d u c t io n  capac ity  an d  a decreased  I L - l r a /  
IL-1 ra tio  in newly d iagnosed  ID D M  patien ts ,  
which  a rgues  for an im balance  in favour  o f  the 
p ro - in f lam m ato ry  cytokines. This  m ay  be im p o r ta n t  
in the pa th o p h y s io lo g y  o f  the beta cell lysis. D u r in g  
the evo lu t ion  o f  the disease, p ro b ab ly  after  all the 
(3-cells are lysed with a cessation  o f  the in f lam m ato ry
process in the pancreas ,  this p ro - in f lam m ato ry  s ta tu s  is 
reversed.
M A TER IA LS AND M E T H O D S
Ten ND-IDDM patients. II LS-IDDM patients and 14 
healthy individuals were studied. The clinical characteristics 
of the patients are given in Table 1. Written consent was 
given by each individual participating in the study. Both 
groups of IDDM patients were non-ketotic at the time of 
sampling. The C-peptide plasma concentration was tested in 
the IDDM patients and in all of them was below 0.1 nmol/1. 
Any sign of infection and or other inflammatory diseases 
served as an exclusion criteria. The newly diagnosed IDDM 
patients were tested within 5 days from diagnosis, while each 
of the long-standing IDDM patients had more than I year 
duration of the disease.
Blood has been drawn from the cubital vein in 4-ml 
sterile tubes containing 48 j.tl EDTA (Vacutainer Systems, 
Becton and Dickinson, Rutherford. NJ). Plasma was 
separated and stored at —20 C until the assays were 
performed. All samples were collected between 7 and 
8 a.m. The ex vivo lipopolysaccharide-stimulated cytokine 
production was assesed as described elsewhere.:: Briefly, the 
blood was drawn in another two tubes of 4 ml as described 
above. The tubes were incubated 24 h at 37 C with the 
addition of 50j.il of lipopolysaccharide (LPS) (LPS: E. co/i 
serotype 055:B5. Sigma Chemical Co., St Louis, MO) 
containing 0.8 mg ml (final concentration of LPS: 10 jig/ml). 
After 24 h. the tubes were centrifuged, plasma was collected 
and stored at —20 C until assay.
Measurement of IL-1 (3. IL-lra and TN F alpha. IL-1 (^  
and IL-lra concentrations were measured as duplicates using 
a quantitative enzyme immunoassay (QuantikineIM. R&D 
Systems Europe, Abingdon, UK) according to the instruc­
tions of the manufacturer. Both kits used a specific 
monoclonal antibody bound to a solid phase, and a specific 
polyclonal antibody conjugated to horseradish peroxidase. 
The specified detection limit for IL-1 (3 was 3.9 pg/ml. and 
for IL-lra was 46.9 pg/ml. TN F alpha was determined by 
an ELISA kit (Boehringer Mannheim, Germany), using 
two mouse monoclonal antibodies directed against two 
different epitopes of the human TNF?.. The specified 
detection limit was 32 pg/ml. Samples from 5 ND-IDDM , 4 
LS-IDDM and 10 healthy controls were also tested using a 
radio-immunoassay method, as described previously.9
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Statistical analysis
Cytokine concentrations are expressed as mean ±  SD. 
Differences between the groups were analysed using the 
Kruskal Wallis test with chi-square approximation. Differ­
ences were considered significant when P value was below
0.05.
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